A guidance of model selection for genomic prediction based on linear mixed models for complex traits.

Abstract

Brain imaging outcomes are important for Alzheimer’s disease (AD) detection, and their prediction based on both genetic and demographic risk factors can facilitate the ongoing prevention and treatment of AD. Existing studies have identified numerous significantly AD-associated SNPs. However, how to make the best use of them for prediction analyses remains unknown. In this research, we first explored the relationship between genetic architecture and prediction accuracy of linear mixed models via visualizing the Manhattan plots generated based on the data obtained from the Wellcome Trust Case Control Consortium, and then constructed prediction models for eleven AD-related brain imaging outcomes using data from United Kingdom Biobank and Alzheimer’s Disease Neuroimaging Initiative studies. We found that the simple Manhattan plots can be informative for the selection of prediction models. For traits that do not exhibit any significant signals from the Manhattan plots, the simple genomic best linear unbiased prediction (gBLUP) model is recommended due to its robust and accurate prediction performance as well as its computational efficiency. For diseases and traits that show spiked signals on the Manhattan plots, the latent Dirichlet process regression is preferred, as it can flexibly accommodate both the oligogenic and omnigenic models. For the prediction of AD-related traits, the Manhattan plots suggest their polygenic nature, and gBLUP has achieved robust performance for all these traits. We found that for these AD-related traits, genetic factors themselves only explain a very small proportion of the heritability, and the well-known AD risk factors can substantially improve the prediction model.